Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study (Q28202824)
Jump to navigation
Jump to search
scientific article (publication date: 15 January 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study |
scientific article (publication date: 15 January 2003) |
Statements
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study (English)
0 references
15 January 2003
0 references
21
0 references
2
0 references
211-22
0 references